Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.570
+0.060 (3.97%)
At close: Oct 15, 2025, 4:00 PM EDT
1.570
0.00 (0.00%)
Pre-market: Oct 16, 2025, 8:00 AM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $96.38 million as of October 16, 2025. Its market cap has decreased by -85.98% in one year.
Market Cap
96.38M
Enterprise Value
-106.12M
1-Year Change
-85.98%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $96.38M, a decrease of -86.93%. That is a compound annual growth rate of -31.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 92.70M | -88.43% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.92B |
| Johnson & Johnson | 458.16B |
| AbbVie | 410.87B |
| UnitedHealth Group | 324.46B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.30B |